Loading, Please Wait...
SANTA BARBARA, Calif., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to present at the 8th Annual SVB Leerink Global Healthcare Conference in New York, NY.
|Event:||8th Annual SVB Leerink Global Healthcare Conference|
|Date:||Wednesday, February 27, 2019|
|Location:||Lotte New York Palace, NY|
Audio webcasts of the Company’s presentations will be made available on the investor relations section of Sientra’s web site at http://www.sientra.com. Replays of the presentations will be available for 90 days.
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its OPUS™ breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprises its miraDry® system, which is approved for sale in over 40 international markets, and is the only non-invasive FDA-cleared device for the permanent reduction of underarm sweat, odor and hair of all colors.
(*) Data on file